Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Arunjyoti Bio Ventures Ltd has informed BSE that its trading window for dealing in company securities will remain closed from January 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter ending December 31, 2025. The closure applies to all designated persons, their immediate relatives, and connected persons covered under the company's Code of Conduct. A board meeting will be scheduled separately to consider and approve the Q3 FY26 unaudited financial results. The intimation was signed by Whole-Time Director Pabbathi Badari Narayana Murthy.
This is a routine regulatory compliance announcement. It signals that the company is preparing to announce its Q3 FY26 results soon but places no immediate restrictions on retail investors. No material impact on the stock price is expected from this disclosure alone.